Parameters such as microsatellite instability, tumor mutation burden (TMB), PD-L1 expression, and tumor infiltrating lymphocyte (TIL) counts have already been identified as markers with likely prognostic value in patients with cancer [13–17]. Here, CD274 is linked to cancer.